Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 2145 - 2152 of 12011 results
FTC Is Scrutinizing Amazon's $1.7B Takeover Of iRobot. What Happens Next?
September 27, 2022| News
Double Homicide Prompts ERISA Suit
September 27, 2022| News
SEC Adopts Pay Versus Performance Compensation Disclosure Requirements
September 26, 2022| Advisory| Viewpoint
New York Office of Medicaid Inspector General Proposes Regulations on Self-Disclosure Program
September 26, 2022| Blog| Viewpoint
Deal Watch: Where Did All the IPOs Go?
September 26, 2022| News
USCIS Started the Third Phase of Its Premium Processing Implementation for Certain Previously Filed Form I-140 Petitions
September 22, 2022| Alert| Viewpoint
OCR HIPAA Privacy Rule Enforcement Roundup: Right of Access Initiative and Improper PHI Disposal
September 22, 2022| Blog| Viewpoint
Why Counsel Should Watch Novartis SCOTUS Appeal
September 22, 2022| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|